What is the appropriate amoxicillin/clavulanate dosing for a 4‑year‑old child weighing 15 kg?

Amoxicillin-Clavulanate Dosing for a 4-Year-Old Weighing 15 kg

For a 4-year-old child weighing 15 kg, prescribe high-dose amoxicillin-clavulanate at 90 mg/kg/day of the amoxicillin component (1,350 mg total daily) divided into two doses of 675 mg every 12 hours. This high-dose regimen is specifically indicated because children under 5 years meet age-based criteria for enhanced pneumococcal coverage. 1

Weight-Based Calculation

• The calculation is straightforward: 15 kg × 90 mg/kg/day = 1,350 mg total daily dose of amoxicillin, administered as 675 mg twice daily (every 12 hours). 1
• Using a 400 mg/5 mL suspension (the high-dose 14:1 formulation), each dose equals approximately 8.4 mL twice daily. 1
• This 14:1 ratio formulation (90 mg/kg amoxicillin with 6.4 mg/kg clavulanate) minimizes diarrhea compared to other ratios while maintaining full efficacy against β-lactamase-producing organisms. 1

Why High-Dose Is Mandatory at This Age

• Age < 5 years is an independent indication for high-dose therapy, regardless of other risk factors, because this age group has higher rates of penicillin-resistant Streptococcus pneumoniae colonization and infection. 1, 2
• The high-dose regimen achieves middle-ear and sinus fluid concentrations adequate to overcome penicillin-resistant S. pneumoniae with MICs up to 2–4 mg/L. 1
• Standard-dose amoxicillin-clavulanate (45 mg/kg/day) fails to achieve therapeutic concentrations against resistant organisms and leads to treatment failure. 1

Additional High-Dose Indications Present

• If this child also attends daycare, has received antibiotics in the past 30 days, has incomplete Haemophilus influenzae type b vaccination, or lives in an area with >10% pneumococcal resistance, these are additional reasons for high-dose therapy—but age alone already mandates it. 1

Treatment Duration by Indication

• Acute otitis media: 10 days of therapy. 1
• Acute bacterial rhinosinusitis: Continue for 7 days after symptom resolution, with a minimum total of 10 days. 2
• Community-acquired pneumonia: 10 days of therapy. 1, 3
• Lower respiratory tract infections: 10 days of therapy. 1

Expected Clinical Response & Monitoring

• Clinical improvement (reduced fever, decreased pain, improved oral intake) should be evident within 48–72 hours of starting therapy. 1, 2
• If no improvement or clinical worsening occurs after 48–72 hours, reassess for complications (empyema, mastoiditis, treatment failure), consider resistant organisms including MRSA, and obtain further diagnostic studies. 1, 3

Critical Dosing Pitfalls to Avoid

• Do not use standard-dose regimens (45 mg/kg/day or lower) in children under 5 years—this is the most common and dangerous dosing error, leading to subtherapeutic concentrations and clinical failure. 1, 2
• Do not substitute two 250 mg/125 mg tablets for one 500 mg/125 mg tablet—the clavulanate ratios differ and are not interchangeable. 4
• Do not use age-based dosing from older British guidelines (e.g., "5 mL of 125/31 suspension three times daily")—these outdated recommendations provide only 20–25 mg/kg/day and are inadequate for current resistance patterns. 1, 2
• Verify the suspension concentration before dispensing—the 400 mg/5 mL (14:1 ratio) formulation is specifically designed for high-dose twice-daily therapy, while the 250 mg/5 mL formulation requires three-times-daily dosing and delivers lower total exposure. 1

Penicillin Allergy Alternatives

• For non-anaphylactic penicillin allergy, use a second- or third-generation cephalosporin (cefdinir 14 mg/kg/day divided twice daily, cefpodoxime, or cefuroxime) under supervision—cross-reactivity risk is only 1–3%. 2, 3
• For IgE-mediated (Type I) anaphylactic reactions, prescribe levofloxacin 16–20 mg/kg/day divided every 12 hours (maximum 750 mg/day) or azithromycin 10 mg/kg on day 1, then 5 mg/kg/day on days 2–5, acknowledging inferior efficacy compared to β-lactams. 2, 3

Administration Guidance

• Administer at the start of meals to enhance clavulanate absorption and minimize gastrointestinal side effects. 4
• Common adverse effects include diarrhea (occurs in approximately 25% vs. 15% with placebo) and diaper dermatitis; these do not require discontinuation unless severe. 1
• Complete the full prescribed course even if symptoms improve early—stopping at 3–5 days increases relapse risk and promotes resistance. 1, 2